1/21/2016
CUTANEOUS MANIFESTATIONS OF SYSTEMIC DISEASE Kayla Bliton, DO McLaren Macomb Family Medicine PGY-3
SCOPE OF PRESENTATION
Common Derm Terminology
Reveal associations between internal disease and the skin Diabetes Mellitus Thyroid Disorders Rheumatological Disorders Vasculitis Renal Disease Pulmonary Disease Gastrointestinal Disease
Recognize the Lesion
Not on Treatment
1 1/21/2016
REVIEW DERM TERMINOLOGY
PRIMARY LESIONS
Definition – a lesion that is directly associated with a disease process
Measured in maximum diameter
Macule – flat lesion < 1cm
Patch – flat lesion ≥ 1cm
Papule – palpable lesion < 1cm
Nodule – palpable lesion ≥ 1cm – generally round
Plaque – palpable lesion ≥ 1cm – generally flat
Tumor – mass ≥ 2cm
Morbiliform – macules and papules together – NOT Maculopapular
2 1/21/2016
PRIMARY LESIONS
Vesicle – fluid filled blister ≤ 1cm
Bulla – fluid filled blister > 1cm
Pustule – small elevations in the skin filled with purulent material
SECONDARY LESIONS
Definition – modification of a primary lesion that results from evolution of the primary lesion or is caused by mechanical means
Scales – masses of keratin
Crusts – dried serum, pus or blood
Excoriations – punctate or linear abrasion made by mechanical means
Fissures – linear cleft
Erosions – loss of part or all of the epidermis
Ulcers – complete loss of epidermis and part of dermis
Scars – new connective tissue replacing the dermis or deeper
3 1/21/2016
DIABETES MELLITUS
DM
DIABETES MELLITUS
Prevalence in US: ~9% 30% will have a cutaneous manifestation at some point Type 1 – more AI associated lesions Type 2 – more cutaneous infections Overall prevalence of skin disorders is the same between types 1 and 2 Skin lesion usually follow the diagnosis but may be seen first
4 1/21/2016
DM
DIABETES MELLITUS OUTLINE
Diabetic Dermopathy Acanthosis Nigricans Tripe Palms Necrobiosis Lipoidica Diabetic Bullae Eruptive Xanthomas Granuloma Annulare
DM
DIABETIC DERMOPATHY
Characteristics #1 cutaneous manifestation of DM 40% prevalence in DM pts
M:F = 2:1 70% of diabetic men over 60 yo
Does occur in people without DM – if ≥4 lesions – specificity is high for DM
5 1/21/2016
DM
Lesion Asymptomatic
Start as small, dull- red papules atrophic, hyperpigmented scars
Found mainly on the shins
DM
ACANTHOSIS NIGRICANS
Lesion Hyperpigmented, velvety plaques, symmetric, grey/brown/black Body folds – neck and axilla Blacks and Hispanics > Whites
6 1/21/2016
DM
3 different types Type 1
Extensive and sudden onset
Adenocarcinoma of the GI tract
Suspect if many lesions in different body areas in non- obese male over 40 yo
Type 2
Familial AN
AD – seen at birth or early childhood
Not assoc. with cancer
DM
Type 3 Most common type of AN Overall prevalence unknown ~20% of all pts Neck, axilla and groin Obese pts Most have clinical or subclinical IR
Also assoc. with other disease states that have atypical glucose metabolism
PCOS, Acromegaly, Gigantism, Cushing syndrome, DM, Addison’s disease, Prader-Willi Syn, Hypothyroidism, Insulin resistance
10% of Renal transplant pts
7 1/21/2016
DM
TRIPE PALMS
Characteristics AKA acanthosis palmaris Thick, velvety palms Can occur with AN, DM
Associations 95% of pts with tripe palms have cancer
77% also involve AN – gastric cancer If only on palms – lung cancer
Presenting symptom in 40% of pts with cancer
DM
NECROBIOSIS LIPOIDICA
Characteristics Assoc with DM 3X more common in women 20-40 yo Can be seen in elderly or kids Not painful
Lesion Small, well-circumscribed and elevated red papules +/- scale Does not disappear under pressure Usually anterior shin
8 1/21/2016
DM
Evolves into irregularly oval lesions Well defined boarders and a smooth, glistening surface Center is depressed and sulfur yellow
Central area atrophies and telangiectasias can be seen 1/3 will develop ulcerations Spontaneously resolves in ~15% with scarring
DM
Necrobiosis Lipoidica Diabeticorum
60% are found in patients with Insulin Dependent DM 20% occur in patients at risk for DM
IDDM – onset avg 22 yo NIDDM – onset avg 49 yo
9 1/21/2016
DM
DIABETIC BULLAE
Characteristics Rare Appear after relative hypoglycemia Most heal in 4-5 weeks without scarring Can result in chronic ulceration
Lesions Noninflammatory, painless blistering usually in acral areas Lower legs - ≥ 10cm
DM
ERUPTIVE XANTHOMAS
Characteristics Most common causes
Uncontrolled type 2 diabetes and hypertriglyceridemia May also be seen in
Hypothyroidism and chronic renal failure Meds
Estrogens, steroids, systemic retinoids +/- pruritus
10 1/21/2016
DM
Lesion Seen all over body
Extensor areas (elbows, thighs, knees), intertriginous areas (axilla, groin), oral mucosa Sudden crops of non-tender yellow, red or brown papules with a red rim
DM
GRANULOMA ANNULARE
Characteristics M:F = 1:2 Usually will spontaneously resolve, usually 3-4 years, w/o scars Idiopathic Localized GA Lesions Diffuse and symmetric, papular or annular Neck, upper trunk and proximal UE, back of hands Asymptomatic to severe pruritus
11 1/21/2016
DM
Localized GA Usually found on dorsal or lateral hands and feet Children and young adults Can be assoc. with AI thyroiditis
Generalized GA Examples of > 10 lesions Generalized GA Women in 50s and 60s May be assoc. with DM, dyslipidemia, HIV
DM
SCLEREDEMA
Characteristics Late onset, long duration IDDM M:F = 10:1, obese Control of DM doesn’t control Scleredema
Lesion Insidious onset of woody (stiff) induration and thickening of the skin and the mid-upper back, neck and shoulders Sharp step-off from involved to normal skin. Skin looks thickened – dermis expanded 2-3x
NOT SCLERODERMA – no hyalinization (change in skin to glassy appearance)
12 1/21/2016
THYROID DISEASE
Thyroid
THYROID DISEASE OUTLINE
Hyperthyroidism Graves’ Disease Pretibial Myxedema Scleroderma Hypothyroidism Vitiligo
13 1/21/2016
Thyroid
HYPERTHYROIDISM
Skin surface Warm, moist, smooth Bronzed appearance Palmar Erythema Facial Flushing Pre-treatment Post-treatment
Hair Texture Thin Downy Non-scarring diffuse alopecia
Thyroid
Nail Changes ~5% pts Plummer Nail
Concave nail
Distal separation
Not specific
14 1/21/2016
Thyroid
GRAVES’ DISEASE
Characterized by: 20-30 years M:F ratio – 1:7 #1 cause of non-iatrogenic hyperthyroidism
Skin manifestations almost only associated with Graves’ Disease (Diamond Triad) Ophthalmopathy Pretibial Myxedema Thyroid Acropachy
Thyroid
THYROID ACROPACHY
Characteristics 1% of Graves pts Triad:
Digital clubbing
Soft tissue swelling of hands and feet
New periosteal bone formation in distal long bones
15 1/21/2016
Thyroid
PRETIBIAL MYXEDEMA
Characteristics 4% of Graves pts AKA Graves Dermopathy Late manifestation, seen with ophthalmopathy in 99%
Lesion: Soft tissue swelling and new bone formation Bilateral shins Nodules and plaques Thick, hyperpigmented, firm skin
Thyroid
SCLEROMYXEDEMA
Characteristics Affects middle aged adults Not common AKA papular mucinosis
Lesions Many, waxy papules in pink, white or yellow Found on face, trunk, axillae, extremities
Lesion are due to hyaluronic acid accumulation in the dermis
16 1/21/2016
Thyroid
HYPOTHYROIDISM
Middle aged women Diffuse hair loss, coarse / brittle hair Myxedema - swelling of face and underlying tissues
Pre-treatment Post-treatment
Thyroid
Cutis verticis gyratum Folds and furrows on the scalp
Onycholysis
17 1/21/2016
Thyroid
Loss of lateral third of eyebrows Chronic periorbital infiltration
Carotenemia Yellow tint to skin Palms / soles Decreased hepatic conversion of beta- carotene to Vitamin A
Thyroid
VITILIGO
Characteristics Onset 10-30 yo Prevalence .5-1% in most countries India >8% Women
Autoimmune related #1 - thyroid disease IDDM
Lesion Acquired depigmentation through destruction of melanocytes surrounded by normal border Hair loses pigmentation
Ocular abnormalities more common
18 1/21/2016
Thyroid
Generalized pattern
Most common of 6 different types of vitiligo
Symmetric involvement
Most common areas – face, upper chest, axilla, groin, dorsal hands
Skin around orifices commonly affected
Trauma can cause lesions – elbows, knees
RHEUMATOLOGY
19 1/21/2016
Rheum
RHEUMATOLOGY OUTLINE
Dermatomyositis Lupus SLE Acute cutaneous Subacute cutaneous Discoid Rheumatoid Arthritis
Rheum
DERMATOMYOSITIS
Inflammatory connective tissue disease that classically involves the skin (dermato-) with muscle inflammation (- myositis)
Symmetric proximal muscle weakness
Amyopathic Dermatomyositis – only skin disease
M:F = 1:2 Black:White = 4:1
Painless, intense pruritus
20 1/21/2016
Rheum
Pathognomonic features
Heliotrope Rash
Gottron Papules
Heliotrope Flower
Rheum Shawl Sign
Holster Sign
21 1/21/2016
Rheum
Mechanic Hands Periungual Hyperkeratotic scale on lateral Telangiectasias digits or palms
Rheum
20-25% are assoc with malignancy
Increased risk for developing malignancy within 3 years after the diagnosis Increased risk if > 40 yo
Usually Adenocarcinoma Women – Ovarian and Breast Cancer Men – Gastric Cancer and Lymphoma
22 1/21/2016
Rheum
LUPUS
Characteristics Autoimmune disorder Young adult women. M:F = 1:2 Fever and arthralgia Cutaneous lesions in 80%
Can be systemic (Systemic Lupus Erythematosus) or cutaneous (Discoid Lupus Erythematosus)
Can be acute (Acute Cutaneous Lupus Erythematosus or Subacute Cutaneous Lupus Erythematosus) or chronic (Discoid Lupus Erythematosus)
Rheum
SYSTEMIC LUPUS ERYTHEMATOSUS
Diagnostic Criteria by the American College of Rheumatology Need 4/11
1. Malar Rash* 2. Discoid Rash* 3. Photosensitivity* 4. Oral Ulcers – 21%* 5. Arthritis 6. Proteinuria >.5g/day or casts 7. Neurologic disorders – seizures or psychosis 8. Pleuritis / pericarditis 9. Blood abnormality –hemolytic anemia, leukopenia, thrombocytopenia 10. Immunologic disorders 11. Positive ANA
Can have at different times or at the same time
23 1/21/2016
Rheum
ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Malar rash Butterfly rash Transient erythematous patch on cheeks and bridge of nose – can be on the ears and chest Typically avoids the nasolabial fold
Lasts days to weeks Resolves without scarring
Seen in ~60% of systemic lupus Rarely occurs in patients without systemic disease
Rheum
Bullous lesions Single or group of vesicles or bullae Sun-exposed areas Usually meets criteria for SLE
Vascular lesions Seen in 50% of SLE pts Fingers or toes
telangiectasias, edema, erythema
24 1/21/2016
Rheum
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE)
Characteristics White woman 15-40 yo 30% of pts with lesion will have systemic disease
20% will also have discoid lupus Present in ~15% of the SLE pts
Can be drug induced
Most likely HCTZ
Anti-histone antibodies – non-specific
Rheum
Lesion Annular, scaly, erythematous patches Photosensitivity – 50% - face, neck, chest, back, arms Resolves without scarring
25 1/21/2016
Rheum
DISCOID LUPUS ERYTHEMATOSUS
Characteristics Chronic lesion Above the neck
face, scalp, concha or the ear and external canal May see periorbital edema or erythema Seen in ~20% of SLE pts 5% of pts with lesion will have systemic disease Mucosal involvement seen in 25%
Rheum
Lesions Erythematous patch or thin plaque Face, scalp, conchal bowl of the ear Leads to atrophic or hyperkeratotic, hairless patches, scarring
Patients with scarring due to lupus lesion need to be monitored for any changes or indications of skin cancer
26 1/21/2016
Rheum
RHEUMATOID ARTHRITIS
Many patients have skin involvement from the disease or medications to treat RA
Lesions - Rheumatoid Nodules #1 cutaneous manifestation ~30% Firm, asymptomatic subcutaneous nodules over extensor joints Side effect of Methotrexate - accelerated nodulosis
VASCULITIS
27 1/21/2016
Vasc
VASCULITIS OUTLINE
Definitions Cutaneous Small Vessel Vasculitis Urticarial Vasculitis Henoch-Schönlein Purpura
Vasc
DEFINITIONS
Petechiae Pinpoint areas of RBCs – nonblanching red macules Abnormal platelet quantity or function, infectious process or abnormal vasculature
Purpura Presence of extravascular RBCs in the dermis Cause by vascular inflammation, external injury
Vasculitis Clinical and pathological process characterized by inflammation and necrosis of blood vessels
28 1/21/2016
Vasc
Palpable purpura Active, inflammatory process
small vessel vasculitis injury to the capillary beds
Palpable
damaged blood vessel Purpura
secondary bleeding into the dermis
May be a primary process or may occur secondary to another disease
Vasc
CUTANEOUS SMALL VESSEL VASCULITIS
Characteristics AKA leukocytoclastic vasculitis Fever, malaise, arthralgia
Lesion Palpable purpura is hallmark Single group of lesions +/- edematous papules and wheals Dependent areas Asymptomatic +/- itching or burning Derm referral for complete workup Resolve in 3-4 weeks
29 1/21/2016
Vasc
Causes:
Idiopathic 50%
Infection β - hemolytic Group A Strep, Mycoplasma, Mycobacterium tuberculosis
Exposure to new medication Meds in every class Can be hours to years after exposure β-lactam antibiotics, NSAIDs, diuretics
Connective tissue disease
Malignancy Lymphoproliferative neoplasms Solid tumors – Lung, Colon, GU, Breast
Vasc
URTICARIAL VASCULITIS
Lesion Persistent urticarial plaques lasting >24 hours Urticaria presenting with tingling pain Resolves with blue hyperpigmentation
50% underlying autoimmune condition
30 1/21/2016
Vasc
HENOCH-SCHÖNLEIN PURPURA
Characteristics Subtype of leukoclastic vasculitis Children or young adults Typically follows an infection IgA found in affected vessels on biopsy
Vasc
Lesion Palpable purpura on lower legs and buttocks
Assoc with arthritis, arthralgia, abdominal pain
Risk of renal disease – higher risk if lesions are above the waist
31 1/21/2016
NEPHROLOGY
Nephro
NEPHROLOGY OUTLINE
Pruritus Calciphylaxis
32 1/21/2016
Nephro
PRURITUS
Characteristics End Stage Renal Disease Intense, unremitting itch chronic scratching secondary lesion (excoriations, lichenification, hyperpigmentation)
Secondary Lesions Prurigo Nodularis
hyperkeratotic hyperpigmented papules and nodules
Nephro
Lichen Simplex Chronicus Thickened, chronic eczematous, scaly patches
Kyrle’s Disease Umbilicated, hyperpigmented papules with a central keratin core
33 1/21/2016
Nephro
CALCIPHYLAXIS
Characteristics
ESRD abnormal calcium and phosphorus balance
calcification in the lumen of arterial vessels
decreased circulation to the skin leading to ischemia and necrosis
<5% with ESRD will have calciphylaxis
Poor prognosis – 60-80% die within 6 months
Nephro
Lesions Painful lacy purpuric patches
bullae, ulcerations with a tough eschar
Center is dusky and may have black necrotic areas
Lower extremities
More proximal may relate to worse disease
34 1/21/2016
PULMONOLOGY
Pulm
PULMONOLOGY OUTLINE
Sarcoidosis Erythema Nodosum Erythema Gyratum Repens
35 1/21/2016
Pulm
SARCOIDOSIS
Characteristics Chronic, multisystem inflammatory disease Pts form granulomatous tissue in affected area Black women in 30s 25-30% have skin involvement AKA “The great imitator” 20% of pts will have skin disease before other symptoms
Lesions White pts Erythema nodosum is as common as specific cutaneous signs 10% have both types of cutaneous sarcoidosis Black pts Erythema nodosum much less common 50% have specific cutaneous manifestations
Pulm
Papular sarcoid Most common specific cutaneous lesion <1cm Small papules – AKA miliary sarcoid Face, eyelids, neck, shoulder
Lupus pernio Thickened, purple, hyperpigmented nodules Around the nose Chronic, refractory
36 1/21/2016
Pulm
Annular Sarcoid Papular lesion arranged in annular pattern Central clearing with possible atrophy and scarring alopecia Head and neck Sun exposed area
Classic cutaneous sarcoidosis Purple papules or palpable plaques Granulomatous lesions – sites of trauma (scars or tattoos)
Pulm
ERYTHEMA NODOSUM
Characteristics Reactive process from the inflammation of the septa in fat lobules (panniculitis) #1 form of panniculitis
Pt may have low grade fever, malaise, arthralgia before skin lesions Any age, most common – young adult women Lesions come and go Most resolve over 4-6 weeks – typically self limiting
37 1/21/2016
Pulm
Lesions Tender, subcutaneous nodules Convex appearance Slightly red in the acute phase Bilateral and symmetrical Distal lower extremities
can also appear on the trunk, thigh, or upper extremities
Pulm
Associations Most common nongranulomatous lesion in Sarcoidosis, usually seen in the acute phase
Infections, Meds, Systemic diseases, Idiopathic
#1 infection – Streptococcal
Meds – Antibiotics, OCPs, Hormone therapy
Systemic – Sarcoidosis, IBD
38 1/21/2016
Pulm
ERYTHEMA GYRATUM REPENS
Lesion appearance wavy, erythematous bands with scale concentric pattern woodgrain pattern migrates quickly – up to 1cm / day
Characteristics Severe pruritus Eosinophilia on lab test
Pulm
Malignancy 70% have malignancy Most likely lung cancer Also breast, cervical, GI May also be caused by medications or TB
Skin manifestation appear ~9mo before cancer is detected
39 1/21/2016
GASTROENTEROLOGY
GI
GASTROENTEROLOGY OUTLINE
Inflammatory Bowel Disease Pyoderma Gangrenosum Porphyria Cutanea Tarda Cryoglobulinemia
40 1/21/2016
GI
INFLAMMATORY BOWEL DISEASE
Erythema nodosum #1 skin manifestation 20% Women Ulcerative colitis
GI
Can also have cutaneous Crohn’s disease Oral involvement
20% - mucosal hypertrophy and fissuring
Granulomas on biopsy
Young men
Pyostomatitis vegetans
intraoral pustules and ulcerations
41 1/21/2016
GI
PYODERMA GANGRENOSUM
Characteristics Intense neutrophilic inflammation and invasion Adults 40-60 yo When active may develop new sites at areas of trauma Needle sticks Diagnosis of exclusion
Lesions Lower extremities and trunk Presents as: Painful ulcers – classically Bullae Pustulonodules Vegetative plaques Ulcers expand with edematous, rolled border Violet hue Annular rings
GI
Associated with underlying disease in 50-75% of patients IBD is most common UC > Crohn’s
Lesions are pustular lesions that do not ulcerate May be autoimmune or hematologic (AML)
42 1/21/2016
GI
PORPHYRIA CUTANEA TARDA
Characteristics Accumulation of porphyrins due to an enzyme deficiency that is essential in heme production
Uroporphyrinogen decarboxylase Affects CNS, skin and other organs
Most common is a sporadic, non-familial form ~80% Most common porphyria Onset in 40s Photosensitivity on sun exposed areas
GI
Lesions Bullae in sun exposed areas (dorsal hands)
Rupture easily and leave small ulcers Skin heals leaving milia, hyperpigmentation or small scars Hypertrichosis on dorsal hands or lateral face
43 1/21/2016
GI
Associations ESLD are at risk of PCT
Alcohol abuse, hemochromatosis, ~50% HCV infection
3.5x increased risk of developing Hepatocellular Carcinoma
~15% pts with adult onset type 2 DM will have PCT
10 years after dx of PCT HIV infection Estrogen treatment
Increasing seen in women after the invention of OCPs
60% men and 40% woman
GI
CRYOGLOBULINEMIA
Characteristics Cryoglobulins - cold precipitating immunoglobulins that are soluble at body temp but precipitate peripherally under 37˚C causing disease
Side effects due to hyperviscosity Glomerulonephritis, neuropathy, arthritis, pulmonary inflammation
Lesions Palpable purpura – lower extremities or dependent areas Most common sign of mixed cryoglobulinemia
44 1/21/2016
GI
Associations >50% of pts with HCV infection
only 10-15% will develop clinical disease
SLE
Lymphoproliferative disorder
multiple myeloma or macroglobulinemia Purpura, Acrocyanosis, Skin necrosis
BIBLIOGRAPHY
James WD, Berger TG, Elston DM. (2016) Andrew’s Diseases of the Skin: Clinical Dermatology 12th Edition.
Schwarzenberger K, Ende J, et al (2012) MKSAP 16
Van Linthoudt D, et al. (July 1996) “Scleromyxedema with myopathy and hyperthyroidism”. J Rheumatology (7):1299-301.
Marinella MA. (July 2004) “Henoch-Schönlein Purpura”. N Engl J Med 351-278.
Satish I, et al. (2016) “Rare presentation of a Rare Side Effect”. Am J Gastroenterol. 2009, 848.
45 1/21/2016
Grandinetti LM, Tomcki KJ. (Aug 2010) “Dermatologic Signs of Systemic Disease”. Retrieved on 12/16/15 from www.clevelandclinicmeded.com/medicalpubs
Miller-Keane, O’Toole MT. (2003) Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, 7th Edition.
National Organization for Rare Disorders, (2015) Acanthosis Nigricans. Retrieved on 1/5/16 from rarediseases.org/rare- diseases/acanthosis-nigricans.com
Douglas RS, (2015) “Graves’ Eye Disease or Thyroid Eye Disease”. Retrieved on 1/10/16 from http://www.kellogg.umich.edu/patientcare/conditions/graves.di sease.html
American Diabetes Association, (1995-2016). Diabetes Statistics. Retrieved on 12/27/15 from http://www.diabetes.org/diabetes- basics/statistics/?referrer=https://www.google.com/
THANK YOU
46